
StemInov
Developer of biomedicine and drugs intended to treat people with septic shock. The company is engaged in the clinical development of biomedicine using mesenchymal stem cells from the umbilical cord, e...
Valuation
$0
Share Price
N/A
Total Raised
$17.9M
Last Round
N/A